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SYNAPTIC PLASTICITY
Synaptic plasticity or long-lasting alterations in the efﬁ  cacy of 
synaptic connections between two neurons has been proposed to 
be the cellular substrate of learning and memory (Malinow and 
Malenka, 2002; Bredt and Nicoll, 2003; Collingridge et al., 2004; 
Neves et  al., 2008). Persistent changes in synaptic efﬁ  cacy are 
thought to involve at least two distinct phases – an early phase (on 
the order of minutes to hours) that is independent of new protein 
synthesis and a more long-lasting late phase (on the order of hours 
to days) that is dependent upon new protein synthesis (Bramham 
and Wells, 2007; Bramham, 2008; Richter and Klann, 2009). The 
ﬁ  rst mechanism typically involves activity-dependent alterations 
in the phosphorylation and number of postsynaptic alpha-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA 
receptor) and N-methyl d-aspartate receptors (NMDA receptor), 
which are delivered to the postsynaptic membrane via exocytosis 
and removed via endocytosis (Collingridge et al., 2004; Lau and 
Zukin, 2007; Neves et al., 2008; Holtmaat et al., 2009; Newpher and 
Ehlers, 2009). The second more long-lasting mechanism, postulated 
to underlie long-lasting memory storage, involves local or ‘on-site’ 
protein synthesis in dendrites by translational machinery strategi-
cally localized in and around synaptic sites (Bramham and Wells, 
2007; Bramham, 2008; Richter and Klann, 2009). The identities of 
the newly synthesized proteins that are required to maintain altered 
synaptic efﬁ  cacy are, however, as yet unclear.
Considerable evidence indicates that alterations in synaptic 
strength are locked-in by alterations in structural remodeling. These 
morphological changes include induction of new dendritic spines, 
enlargement of spines already extant, and the splitting of single 
spines into two or more functional synapses (Bourne and Harris, 
2008; Holtmaat et al., 2009; Newpher and Ehlers, 2009). More 
recently, studies involving spine long-term potentiation (LTP), in 
which single spines are activated via photolysis of caged glutamate 
and imaged by means of two-photon microscopy, demonstrate that 
LTP is accompanied by enlargement of dendritic spines (Matsuzaki 
et al., 2004; Harvey and Svoboda, 2007; Harvey et al., 2008; Lee 
et al., 2009).
GENERAL FEATURES OF mRNA TRANSLATION
mRNA translation, a complex process involving the participa-
tion of many proteins and RNAs, is generally divided into three 
phases: initiation, elongation, and termination. Although each of 
these steps serves as a point of regulation to control the amount 
of protein that is produced, initiation is by far the most important 
and the salient features of this segment are important to keep in 
mind when considering how synapse stimulation induces changes 
in the translational apparatus.
Initiation begins with the formation of a ternary complex com-
prised of GTP, met-tRNA, and the initiation factor eIF2 (Pestova 
et al., 2007). Together with additional initiation factors (eIF3, eIF5, 
eIF1, and eIF1A), the ternary complex associates with the 40S ribos-
omal subunit to form a 43S pre-initiation complex (Chaudhuri 
et al., 1999; Majumdar et al., 2003). In mammals, this large bolus 
of factors is recruited to the 5′ end of the mRNA through interac-
tions with the initiation factors eIF4G and eIF3; at this point, it 
is referred to as the 48S pre-initiation complex (Lamphear et al., 
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1995). The DExH box protein DHX29, a putative helicase, is also a 
required component of this complex for the translation of mRNAs 
with highly structured 5′ UTRs (Pisareva et al., 2008). Proper posi-
tioning of the complex on the 5′ end requires the m7G cap-binding 
complex consisting of eIF4E, eIF4G and eIF4A, which together are 
called eIF4F (Gingras et al., 1999). With the aid of the initiation 
factors eIF1, eIF1A, and DHX29, the 48S complex then scans the 
mRNA in the 3′ direction until it encounters an AUG initiation 
codon in the correct context, generally the ﬁ  rst AUG, where it is 
joined by the 60S subunit to begin polypeptide elongation (Pestova 
et al., 1998; Pestova and Kolupaeva, 2002; Pisareva et al., 2008).
The association between eIF4E, the cap binding factor, and 
eIF4G, is often regulated upon synaptic activity. The protein 4E-BP 
can bind eIF4E and prevent eIF4G from joining with eIF4E, thus 
abrogating cap-dependent translation. Phosphorylation of 4E-BP 
either directly or indirectly by the kinase mammalian Target of 
Rapamycin (mTOR) causes it to dissociate from eIF4E, thereby 
liberating the factor to bind both the cap and eIF4G and initiate 
translation (Gingras et al., 1999).
SYNAPTIC SIGNALING
A diversity of synaptic signals regulates the translation of dendritic 
RNAs. Such localized stimuli include those that trigger synapse for-
mation, pruning, neurite outgrowth/collapse, activity-dependent 
synaptic plasticity and injury-induced axonal regeneration. A criti-
cal regulator of activity-dependent protein synthesis in dendrites 
is metabotropic glutamate receptors (mGluRs). mGluRs are G 
 protein-coupled receptors enriched at excitatory synapses through-
out the brain where they act to regulate glutamatergic neurotrans-
mission (Nakanishi, 1994; Pin and Duvoisin, 1995; Conn and Pin, 
1997). Group I mGluRs (mGluR1/5) activate phospholipase C, 
leading to Cai
2+ mobilization, and the extracellular signal-regulated 
kinase (ERK)–mitogen-activated protein kinase (MAPK) pathway 
through which they modulate signal-to-nucleus communication. 
Signaling by mGluR1/5 is critical to synaptic circuitry formation 
during development and is implicated in forms of plasticity includ-
ing LTP (Aiba et al., 1994), long-term depression (LTD) (Aiba et al., 
1994; Oliet et al., 1997; Palmer et al., 1997; Huber et al., 2001; Bear 
et al., 2004) associative learning (Aiba et al., 1994) and cocaine 
addiction (Kenny and Markou, 2004). mGluR1/5 elicit synapse-
 speciﬁ  c modiﬁ  cations in synaptic strength and spine morphol-
ogy by stimulating rapid local translation of dendritic mRNAs 
 including  Fmr1, encoding fragile X mental retardation protein 
(FMRP) (Greenough et al., 2001). Expression of mGluR-LTD at 
Schaffer collateral to CA1 pyramidal cell synapses is mediated by 
persistent internalization of AMPARs and in adolescent wild-type 
(WT) mice requires de novo protein synthesis (Huber et al., 2000; 
Snyder et al., 2001) that is dependent on the mTOR (Hou and 
Klann, 2004). The protein synthesis dependent is both age and 
region-speciﬁ  c in that CA1 mGluR-LTD in neonates (Nosyreva 
and Huber, 2005) and mGluR-LTD at cortical synapses (Desai et al., 
2006) require neither local protein synthesis nor FMRP function.
Mammalian Target of Rapamycin is a central regulator of cell 
growth and proliferation, autophagy, ribosome biogenesis, and 
translation (Hay and Sonenberg, 2004; Klann and Dever, 2004; 
Sarbassov et al., 2005) and a critical signaling pathway downstream 
of group I mGluRs. In neurons, components of the mTOR  signaling 
cascade are present at synapses and are thought to   inﬂ  uence 
  synaptic plasticity via regulation of local protein synthesis (Tang 
and Schuman, 2002). mTOR is activated in dendrites by stimula-
tion of group I mGluRs (Klann and Dever, 2004) and is required 
for mGluR-LTD at Schaffer-collateral to CA1 synapses (Hou and 
Klann, 2004; Banko et al., 2006; Antion et al., 2008). Growing evi-
dence indicates that dysregulation of mTOR is associated with 
human diseases, including cancer, diabetes, and autism (Jaworski 
and Sheng, 2006; Sabatini, 2006; Dann et al., 2007).
THE MOLECULAR, CELLULAR AND PHYSIOLOGICAL BASIS OF 
THE FRAGILE X SYNDROME
The fragile X syndrome (FXS) is the most common heritable form 
of mental retardation (Chiurazzi et al., 2003; Jacquemont et al., 
2007; Bassell and Warren, 2008) as well as the most common 
known genetic cause of autism (Fryns et al., 1984). FXS is caused 
by loss-of-function mutations in the FMRP, which is encoded by 
the FMR1 gene located on the X chromosome. In humans, the 
FXS typically results from expansion of a CGG repeat sequence in 
the 5′-untranslated region and silencing of the FMR1 gene (Feng 
et al., 1995; Garber et al., 2006). Patients with the FXS exhibit a 
wide-range of neurological deﬁ  cits including cognitive impairment, 
seizures, emotional instability, sleep disorders, attention deﬁ  cits, 
autonomic dysfunction, and autism (Hagerman and Hagerman, 
2002; O’Donnell and Warren, 2002; Chiurazzi et al., 2003; Jin and 
Warren, 2003). FMRP, the gene product of the FMR1 gene, is an 
RNA binding protein that associates with many mRNAs, some of 
which encode proteins important for neuronal development and 
plasticity. FMRP controls activity-dependent dendritic mRNA 
localization (Dictenberg et al., 2008), stability (Brown et al., 2001; 
Miyashiro et al., 2003; D’Hulst et al., 2006; Zalfa et al., 2007; Zhang 
et al., 2007) and translational efﬁ  ciency of dendritic mRNAs in 
response to stimulation of mGluRs (Weiler et al., 1997; Todd et al., 
2003; Muddashetty et al., 2007; Westmark and Malter, 2007; Napoli 
et al., 2008).
FMRP is detected in cell bodies, in dendritic shafts and branch 
points (Ferrari et al., 2007), and at the base of synaptic spines and 
spine heads (Feng et al., 1997). FMRP mRNA is translated near 
synapses in response to neurotransmitter activation (Weiler et al., 
1997); moreover, different models of experience-dependent plas-
ticity such as whisker stimulation (Todd and Mack, 2000), visual 
experience (Gabel et al., 2004) and exposure to enriched environ-
ment (Irwin et al., 2005) also promote FMRP mRNA translation.
Mice lacking FMRP (Bakker et al., 1994) exhibit abnormalities in 
dendritic spine morphology (Bagni and Greenough, 2005), cogni-
tive deﬁ  cits (O’Donnell and Warren, 2002), exaggerated, protein 
synthesis-dependent LTD at Schaffer collateral to CA1 pyrami-
dal cell synapses in adolescent WT mice, but protein   synthesis-
  independent in neonatal WT mice (Nosyreva and Huber, 2005) 
and in Fmr1 KO mice (Huber et al., 2002; Koekkoek et al., 2005; 
Hou et al., 2006; Nosyreva and Huber, 2006; Zhang et al., 2009), 
and decreased LTP in the cortex (Li et al., 2002; Chuang et al., 2005; 
Larson et al., 2005; Zhao et al., 2005). Recent ﬁ  ndings indicate 
that dysregulation of mTOR signaling in the hippocampus is an 
important functional link between overactivated mGluR signaling, 
aberrant protein synthesis, and exaggerated mGluR-LTD in Fmr1 
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are dysregulated in the absence of FMRP. For example, the Fmr1 
KO mouse exhibits aberrant numbers and/or activity of mGluR5 
(Giuffrida et al., 2005; Dolen et al., 2007), NMDA (Gabel et al., 
2004; Desai et al., 2006) and AMPA (Pilpel et al., 2009; Schuett 
et al., 2009) receptor signaling.
A hallmark feature of the FXS in humans, also observed in 
the Fmr1 KO mouse, is that of synaptic spine dysmorphogenesis. 
Spines on hippocampal and cortical neurons of Fmr1 KO mice 
exhibit enhanced density and are thinner and longer than those 
of age-matched WT mice, resembling an immature morphology. 
These observations indicate that FMRP normally controls  processes 
involved in synapse maturation, stabilization, and elimination 
(Bagni and Greenough, 2005). Electrophysiology experiments 
using cultured neurons indicate a delay in establishing synaptic 
connections during a brief window in brain development (Braun 
and Segal, 2000). In the somatosensory cortex, although spine dys-
morphogenesis persists into adulthood (Galvez and Greenough, 
2005; Restivo et al., 2005), it can be rescued if the animals (mice) 
are exposed to enriched environmental conditions (Restivo et al., 
2005; Meredith et al., 2007).
FMRP AND LOCAL PROTEIN SYNTHESIS
Synaptic activity in the brain can trigger long-lasting changes in syn-
aptic strength; i.e., LTP and LTD. Early in development, LTP seems 
to be important for retaining nascent synapses, whereas LTD is 
more directly involved in activity-guided synapse elimination. The 
combination of these two phenomena contributes to the essential 
brain function of learning and memory. Impaired synaptic activity 
almost certainly results in impaired mental development (Vaillend 
et al., 2008). New proteins that contribute to re-arrangements and 
re-assembling of synapse are made locally from mRNAs that are 
trafﬁ  cked to dendrites (Steward and Levy, 1982). Local changes 
in synaptic efﬁ  cacy are protein synthesis dependent (Steward and 
Schuman, 2003; Martin and Zukin, 2006; Lin and Holt, 2008); syn-
aptic activity also promotes an increase in the number of polysomes 
at spines, presumably reﬂ  ecting increased ‘on-site’ local synthesis 
of proteins critical to alterations in synaptic efﬁ  cacy and structural 
remodeling of spines (Ostroff et al., 2002).
In neurons, FMRP is packaged in ribonucleoprotein (RNP) 
granules, some components of which have been identiﬁ  ed (Ohashi 
et al., 2002; Brendel et al., 2004; Kanai et al., 2004; Ling et al., 2004; 
Villace et al., 2004; Dictenberg et al., 2008; Napoli et al., 2008). 
FMRP granules contain several proteins involved in translation 
(Pur alpha and beta, hnRNPU, Staufen, EF1alpha, PAPB1, eIF4E, 
ribosomal proteins), cytoskeleton dynamics (tubulin, tau, actin, 
Rac1, CYFIP), and the movement of molecules and organelles 
(dynein, myosins and kinesins). Importantly, αCAMKII and Arc, 
targets of FMRP that are critical to synaptic plasticity and known to 
be synthesized de novo in response to neuronal activity, are detected 
in these granules (Kanai et al., 2004). FMRP-containing RNP gran-
ules are transported along microtubules in dendrites (Antar et al., 
2004; Ferrari et al., 2007). These data strongly support a role for 
FMRP in dendritic delivery of RNA and regulation of local transla-
tion in speciﬁ  c synaptic compartments.
The molecular mechanism(s) by which FMRP controls trans-
lation has been investigated by assessing the polysome/mRNP 
distribution of the FMRP-containing complex. Unfortunately, 
there is little consensus regarding the results of these  experiments. 
Initially,  FMRP was shown to co-sediment entirely with 
 polyribosomes or even larger granules (Ohashi et al., 2002; Ceman 
et al., 2003; Khandjian et al., 2004; Stefani et al., 2004) or to co-
sediment essentially equally with polysomes and mRNPs (Feng 
et al., 1997; Brown et al., 2001; Ohashi et al., 2002). Other labo-
ratories found that FMRP co-sedimented mainly with the mRNP 
fraction (Siomi et al., 1996; Ishizuka et al., 2002; Zalfa et al., 2003; 
Hock et al., 2007; Napoli et al., 2008). These ﬁ  ndings are sum-
marized in Figure 1. While this apparent discrepancy could arise 
owing to differences in methodologies, brain region or cell type, a 
recent study by Bagni and colleagues shows that FMRP regulates 
synaptic translation at the level of initiation (Napoli et al., 2008). 
These authors showed that FMRP inhibits translation initiation 
through an interacting factor, CYFIP1/Sra1, which binds the cap 
binding factor eIF4E. Interestingly, CYFIP1 binds eIF4E via a novel 
domain with a characteristic ‘reverse L shaped’ structure that is 
also assumed by the canonical eIF4E-binding motif (Marcotrigiano 
et al., 1999). The importance of CYFIP1 in the FMRP-regulatory 
circuit was demonstrated by an increased level of proteins encoded 
by known FMRP target mRNAs upon reduction of CYFIP1 in neu-
rons. Furthermore, the Brain Cytoplasmic RNA 1, another FMRP 
binding partner, increases the afﬁ  nity of FMRP for the CYFIP1-
eIF4E complex in the brain (Napoli et al., 2008).
Translation in neurons is regulated by synaptic activity. In 
  cultured neurons, protein synthesis can be activated by several 
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FIGURE 1 | Model for FMRP activity. FMRP has been reported to sediment 
in both the RNP fractions (i.e., less the 80S monosome) as well as with 
polysomes in sucrose gradients. In the RNP fractions, FMRP is associated 
with CYFIP1 and the cap binding factor eIF4E. Here, we show that CYFIP1 
inhibits translational initiation by binding initiation factor eIF4E and preventing 
assembly of eIF4E with eIF4G. In the polysome fractions, FMRP may inhibit 
protein synthesis by inhibiting polypeptide elongation (i.e., by retarding the 
rate at which ribosomes move along the mRNA). Thus, FMRP may inhibit 
translation at two distinct steps, initiation and elongation. 40S and 60S are the 
ribosomal subunits, 80S is the monosome or complex of the two subunits, 
and m7G is the cap, a modiﬁ  ed nucleotide containing a methyl tag, present at 
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synaptic stimuli such as BDNF and DHPG. BDNF stimulates 
translation at synapses via the mTOR and ERK–MAPK pathways, 
and likely involves the modulation of translational initiation. 
Moreover, BDNF activates the translation of Arc and αCaMKII 
mRNAs (Yin et al., 2002; Schratt et al., 2004; Napoli et al., 2008), 
two FMRP targets (Zalfa et al., 2003; Park et al., 2008). Stimulation 
of neurons by BDNF or DHPG promotes dissociation of CYFIP1 
from eIF4E at synapses, an event associated with initiation of pro-
tein synthesis. Thus, FMRP-dependent translational repression in 
brain is mediated, at least in part, by CYFIP1 (Napoli et al., 2008). 
Activity dependent changes in FMRP phosphorylation is observed 
in dendrites and show a temporal correlation with the translational 
proﬁ  le of select FMRP target transcripts (Narayanan et al., 2007). 
Post-translational modiﬁ  cations of FMRP and or CYFIP1 may 
account for such reversible control of local translation. Finally, 
the temporal activity of FMRP seems also to be regulated by mGluR 
signaling. mGluR-LTD induces a transient, translation-dependent 
increase in FMRP that is rapidly reversed through degradation 
by the ubiquitin-proteasome pathway (Hou et al., 2006). Synaptic 
stimulation also affects the proteasome pathway. NMDA receptor-
dependent synaptic stimulation promotes a redistribution of pro-
teasomes from dendritic shafts to synaptic spines and thus provides 
a mechanism for local protein degradation (Bingol and Schuman, 
2006). Synaptic proteasomal activity seems to affect a large number 
of synaptic proteins including speciﬁ  c postsynaptic scaffolds whose 
turnover after ubiquitination is enhanced. Interestingly, the long-
term activity-dependent increases of CaMKII and PSD-95, encoded 
by two mRNAs that are translationally repressed by FMRP (Zalfa 
et al., 2003; Hou et al., 2006; Muddashetty et al., 2007; Zalfa et al., 
2007) requires proteasome-mediated degradation (Ehlers, 2003). 
These ﬁ  ndings suggest an interplay between mRNA localization 
and FMRP degradation that is integrated with neuronal activity 
and directly regulated by the ubiquitin-proteasome system.
Fragile X mental retardation protein key target mRNAs encode 
proteins involved in synaptic structure and function (Bagni and 
Greenough, 2005; Bassell and Warren, 2008). Among them an 
interesting target candidate is Arc/Arg 3.1 (Zalfa et al., 2003; Park 
et al., 2008). Arc/Arg 3.1 mRNA translation is rapidly up-regulated 
following mGluR stimulation, an effect that is not detected in the 
absence of FMRP. Arc/Arg 3.1 mRNA synaptic translation has been 
proposed to be critical for synapse-speciﬁ  c LTD (Park et al., 2008). 
Thus Arc/Arg 3.1 reduces the number of GluR2/3 receptors leading 
to a decrease in AMPAR-mediated synaptic currents (Rial Verde 
et al., 2006). Consequently, Arc/Arg 3.1 may be one on the ‘key LTD’ 
synaptic proteins whose upregulation would lead to the impaired 
hippocampal mouse LTD observed in FMR1 KO mice. Bear et al. 
(2004) proposed that a net loss of synaptic AMPA and NMDA 
receptors, possibly due to an increased internalization mediated by 
one or several LTD proteins, would contribute to a weakened spine 
and possibly the dysmorphogenesis observed in the FXS.
Fragile X mental retardation protein can speciﬁ  cally recognize 
its mRNA targets in multiple ways: directly via RNA structures 
such as G-quartets and/or G-rich and/or U-rich sequences, via 
BC1 RNA, or microRNAs (Bagni and Greenough, 2005; Bassell 
and Warren, 2008). It is unclear whether the alternative binding 
motifs or non-coding RNAs are speciﬁ  c for different messengers 
or, rather, function as alternative modes to target the same mRNAs 
during development or synaptic response. Further work is needed 
to understand the functional consequences of impaired local pro-
tein synthesis in the developing brain and how this correlates with 
the autistic and FXS phenotypes.
CYTOPLASMIC POLYADENYLATION ELEMENT BINDING 
PROTEIN (CPEB)-REGULATED SYNAPTIC TRANSLATION
The CPEB is an RNA binding protein that recognizes target RNAs 
via speciﬁ  c sequences in their 3′-untranslated regions. CPEB pro-
motes dendritic delivery of mRNAs along microtubules (Huang 
et al., 2003) and polyadenylation-induced translation of mRNAs 
in response to synaptic activity (Wu et al., 1998; Huang et al., 2002; 
Shin et al., 2004; Du and Richter, 2005) (Figure 2 depicts key features 
of CPEB-controlled translation). In neurons, CPEB localizes to the 
cell body and postsynaptic sites and, within dendrites, is packaged in 
RNP granules that localize near synapses. In neurons CPEB targets a 
number of mRNAs that encode proteins critical to synaptic plastic-
ity (Du and Richter, 2005; Pique et al., 2008). Disruption of CPEB 
stunts the development of dendritic arbors and prevents neurons 
from integrating into the functional visual system of Xenopus laevis 
(Bestman and Cline, 2008). Moreover, loss of CPEB activity in mice 
prevents the formation of some forms of synaptic   plasticity and 
interferes with memory formation (Alarcon et al., 2004a; Berger-
Sweeney et al., 2006; McEvoy et al., 2007; Miniaci et al., 2008). 
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FIGURE 2 | Model for CPEB activity. Some mRNAs contain a cytoplasmic 
polyadenylation element (CPE), which is bound by CPEB. CPEB also interacts 
with Maskin (or Neuroguidin, a functionally related protein), which in turn 
interacts with the cap (m7G) binding protein eIF4E. Such mRNAs are 
translationally inactive because Maskin inhibits the association of eIF4E and 
eIF4G, another initiation factor that helps recruit the 40S ribosomal subunit to 
the 5′ end of the mRNA. Cues such as NMDA receptor activation stimulate 
the kinase Aurora A, which phosphorylates CPEB, an event that causes 
poly(A) tail elongation. poly(A) binding protein (PABP) binds the newly 
elongated poly(A) tail and recruits eIF4G. The PABP-eIF4G dimer helps to 
displace Maskin from eIF4E, allowing eIF4G to bind eIF4E and initiate 
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CPEB knockout mouse exhibit reduced theta burst-induced LTP 
at Schaffer collateral to CA1 pyramidal cell synapses of the hip-
pocampus (Alarcon et al., 2004a). In  addition, these mice exhibit a 
deﬁ  cit in extinction of memory, a phenomenon whereby behavioral 
responses diminish and eventually become extinct when there is no 
reinforcement of the memory (Berger-Sweeney et al., 2006; McEvoy 
et al., 2007; Miniaci et al., 2008). Although extinction requires the 
formation of new  memories, the underlying mechanisms by which 
it occurs are probably distinct from those of memory acquisition 
and consolidation (Abel and Lattal, 2001). These data suggest an 
important role for CPEB in linking local protein synthesis and 
morphological plasticity to synaptic plasticity.
Zearfoss et al. identiﬁ  ed growth hormone (GH) as one protein 
whose level is reduced ∼10-fold in the CPEB KO hippocampus 
(Zearfoss et al., 2008). GH mRNA contains no binding sites for 
CPEB, and both GH mRNA and pre-mRNA are reduced in the 
KO versus WT hippocampus, suggesting that an mRNA encod-
ing a transcription factor that regulates GH gene expression is 
under the control of CPEB. Indeed, CPEB controls the synthesis 
of c-jun, which regulates the expression of the GH gene. GH also 
induces LTP in hippocampal slices; GH-induced LTP, like electrical 
  stimulation-elicited LTP, is reduced at CA1 synapses of the CPEB 
KO mouse. Moreover, LTP induced by GH or theta burst stimula-
tion is reduced if polyadenylation is inhibited by the drug cordyc-
epin (3′-deoxyadenosine), which terminates adenylate polymers. 
These and other results suggest that GH acts in both autocrine and 
paracrine fashion to regulate plasticity through CPEB-mediated 
control of c-jun translation.
The CPEB is also present in invertebrates, where it may act as 
a polyglutamine-containing prion-like factor to control plastic-
ity; in Aplysia sensory neurons where CPEB RNA expression has 
been disrupted by an antisense oligonucleotide, long-term facili-
tation is not maintained (Si et al., 2003b). The isoform of Aplysia 
neuronal CPEB differs from the vertebrate CPEB noted above 
in that it contains a high concentration of glutamine residues. 
Polyglutamine can be found in proteins that resemble a prion, an 
infectious agent consisting of self-reproducing protein. The authors 
(Si et al., 2003a,b) suggested that this CPEB isoform could assume 
a prion-like structure following synaptic experience and form an 
indelible synaptic tag. If true, then CPEB, rather than the proteins 
derived from CPEB-regulated translation, would comprise a tag 
that distinguishes experienced from naive synapses. Si et al. (2003a) 
demonstrated that Aplysia CPEB resembled a prion in that it was 
protease resistant and had a fast sedimentation rate in sucrose 
gradients. More compelling evidence came from experiments in 
transduced yeast, where Aplysia CPEB assumed two forms: one that 
aggregated (i.e., prion-like) and one that did not. Very unexpect-
edly, the aggregated form of CPEB bound to RNA and converted 
the nonaggregated form into an aggregated form. Such epigenetic 
inheritance is a hallmark of prion formation and lead the authors 
to opin that synaptic activity could cause neuronal Aplysia CPEB 
to become prion-like and stimulate the translation of RNAs, cause 
it to alter its substrate speciﬁ  city, or release some mRNAs from a 
translationally dormant state. Si et al. (2003a) also suggested that 
once it becomes prion-like, CPEB would need no further stimula-
tion to maintain activity.
Vertebrates contain three additional CPEB-like genes, all of 
which are expressed in the brain (Theis et al., 2003). Two of these 
CPEB-like proteins contain some polyglutamine but they do not 
have a strong afﬁ  nity for the CPEB binding site and do not regulate 
polyadenylation (Huang et al., 2006). Although the relationship 
between vertebrate CPEB proteins and prions, if any, remains to 
be determined, a Drosophila CPEB isoform, Orb2, contains poly-
glutamine and is important for long term memory; when the poly-
glutamine is deleted, long term memory is disrupted (Keleman 
et al., 2007). While this study did not examine prion formation, 
or even mRNA translation, it does point to the glutamine stretch 
of the CPEB isoform as being potentially important for memory 
formation.
CONCLUSIONS
Synaptic plasticity is a key phenomenon in the development and 
function of neuronal networks. Several studies provide strong evi-
dence linking mRNA trafﬁ  cking and dendritic protein synthesis to 
synaptic plasticity. Relatively little is known about how these proc-
esses are interrelated, including coupling of synaptic signalling to 
the translational machinery, selective translation of speciﬁ  c mRNA 
at synapses, and speciﬁ  c delivery of newly transcribed mRNAs to 
activated synaptic sites. Two molecules that connect receptor sig-
nalling to local protein synthesis in spines are CPEB and FMRP. 
CPEB localizes to postsynaptic sites where it regulates translation of 
proteins critical to synaptic plasticity (Du and Richter, 2005; Pique 
et al., 2008), remodeling of dendritic arborization and organization 
of the functional visual system (Bestman and Cline, 2008). CPEB KO 
mice exhibit deﬁ  cits in synaptic plasticity and memory formation 
(Alarcon et al., 2004b; Berger-Sweeney et al., 2006; McEvoy et al., 
2007; Miniaci et al., 2008). These ﬁ  ndings suggest an important role 
for CPEB in linking local protein synthesis and dendritic remodeling 
to synaptic plasticity. Similarly, FMRP localizes to synapses where 
it regulates translation of proteins critical to synaptic plasticity and 
structural remodeling. Fmr1 KO mice exhibit abnormal dendritic 
spines, cognitive deﬁ  cits, aberrant synaptic plasticity in different 
areas of the brain, and a reduced number of mGluR and AMPA 
receptors. Pharmacological or genetic manipulations that attenuate 
activity of group I mGluRs (Dolen et al., 2007) or exposure to an 
enriched environment increases AMPAR subunit abundance in the 
visual cortex (Restivo et al., 2005; Meredith et al., 2007) and rescues, 
at least in part, the hallmark behavioral and synaptic abnormalities 
of the fragile X phenotype. Dissection of the molecular mechanisms 
underlying these rescue experiments represent a starting point in 
our understanding of FMRP function and of the linkage between 
neuronal activity, receptor activation, and local protein synthesis.
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